Related Experiment Video

Updated: May 29, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells

Yakun Ge1, Yuanxin Zhang, Yunpeng Chen

  • 1Key Laboratory for Molecular Enzymology & Engineering of the Ministry of Education, School of Life Science, Jilin University, Changchun 130023, China; E-Mails: yakunge@126.com (Y.G.); zhangyuanxin@126.com (Y.Z.); qsli06@mails.jlu.edu.cn (Q.L.).

International Journal of Molecular Sciences
|September 29, 2011
PubMed

Insights

Silibinin effectively inhibited pancreatic cancer cell growth and induced apoptosis. This suggests silibinin may be a potential agent for pancreatic cancer prevention and therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Silibinin is a known anti-cancer agent in epithelial cancers.
  • Its effects on human pancreatic carcinoma and underlying mechanisms are not fully understood.

Purpose of the Study:

  • To evaluate silibinin's inhibitory effects on pancreatic carcinoma cell proliferation.
  • To investigate silibinin's modulation of cell cycle and apoptosis in pancreatic cancer.

Main Methods:

  • Treatment of human pancreatic carcinoma cell lines (AsPC-1, BxPC-3, Panc-1) with silibinin.
  • Assessment of cell proliferation, cell cycle distribution, and apoptosis.
  • Analysis of silibinin's impact on specific cell cycle phases.

Main Results:

  • Silibinin significantly inhibited proliferation in AsPC-1, BxPC-3, and Panc-1 cells.
  • Silibinin induced apoptosis in these pancreatic cancer cells.
  • Silibinin caused G1 phase cell cycle arrest and reduced S phase in AsPC-1 cells, with less pronounced effects on BxPC-3 and Panc-1 cell cycles.

Conclusions:

  • Silibinin demonstrates potent anti-proliferative and pro-apoptotic effects on human pancreatic carcinoma cells.
  • Silibinin exhibits potential as a chemopreventive agent for pancreatic cancer.
  • Further research into silibinin's mechanisms in pancreatic cancer therapy is warranted.
Keywords:
Silibininapoptosiscell proliferationcell-cycle arrestpancreatic cancer

More Related Videos

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...